Adam Chambers

Director at Shuttle Pharmaceuticals.

Raised on Shuttle Pharmaceuticals filings

$10M

of $10M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: May 15, 2026

Company

Shuttle Pharmaceuticals

Biotech · Gaithersburg, MD

Radiation-sensitizing drug for glioblastoma

Radiation-sensitizing drug for glioblastoma

Investors: 47

Investors: 47
Sector: Biotech
HQ: Gaithersburg, MD

Shuttle Pharmaceuticals filings

Shuttle Pharmaceuticals Form D filings
Filed	Security	Sold of offered	Filing
May 15, 2026	Equity	$10M/ $10M	Form D

EquityFiled May 15, 2026Form D
$10M/ $10M

Works with

Also named on Shuttle Pharmaceuticals filings

Christopher CooperCo-Chief Executive Officer, Form D signerForm D signer Ryan TrasoliniCo-Chief Executive Officer Angel LirianoDirector George ScorsisDirector Yuying LiangChief Financial Officer